Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
210 participants
INTERVENTIONAL
2005-01-31
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Maternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate Decisions
NCT04049799
Fetal Neurobehavior in Non-methadone Maintained Women in Substance Abuse Treatment
NCT00522626
The Effects of Methadone and Buprenorphine on Fetal Neurobehavior and Infant Neonatal Abstinence Syndrome - 1
NCT00218621
Treating the Partners of Drug Using Pregnant Women: Stage II
NCT00496990
Fetal Neurobehavior in Poly-drug Dependent Women
NCT00653692
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
tobacco abstinent contingent voucher
Tobacco abstinent contingent voucher condition
tobacco abstinent contingent
Participants receive vouchers wiht monetary rewards for providing breath samples that show tobacco smoking abstinence
non-contingent
Participants receive vouchers non-contingent upon tobacco use status
non-contingent
Participants receive vouchers regardless of tobacco use status
no voucher
This is the standard care intervention
control
this group receives no vouchers
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
tobacco abstinent contingent
Participants receive vouchers wiht monetary rewards for providing breath samples that show tobacco smoking abstinence
non-contingent
Participants receive vouchers regardless of tobacco use status
control
this group receives no vouchers
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Treatment entry at or before 31 weeks EGA
* Expected to enter drug-free outpatient modality at CAP
* Placed on methadone pharmacotherapy
* Nicotine dependent
* Sufficient literacy and understanding for assessment procedures
* Expected availability for study duration (e.g., complete inpatient stay)
* Able and willing to provide informed consent
* At least 18 years of age
* Confirmed smoker of 10 or more cigarettes
Exclusion Criteria
* EGA of 32 weeks or greater
* 17 years of age or younger
* Undergoing detoxification (non-methadone treatment)
* Unable to provide informed consent
* Currently receiving nicotine replacement products (NRT)
* Current diagnosis of alcohol or benzodiazepine dependence
* Severe medical or psychiatric concomitant conditions that would interfere with treatment or require extended hospitalization.
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
Johns Hopkins University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hendree E. Jones
Adjunct Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hendree E Jones, PhD
Role: PRINCIPAL_INVESTIGATOR
Johns Hopkins University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Johns Hopkins Bayview Medical Center, Center for Addiction and Pregnancy
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Tuten M, Svikis DS, Keyser-Marcus L, O'Grady KE, Jones HE. Lessons learned from a randomized trial of fixed and escalating contingency management schedules in opioid-dependent pregnant women. Am J Drug Alcohol Abuse. 2012 Jul;38(4):286-92. doi: 10.3109/00952990.2011.643977. Epub 2012 Feb 22.
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.